ja.ma/482VQkw Servicio de Geriatra del INCMNSZ repostedThis JAMA patient page covers #GLP1 weight-loss medications, focusing on food craving reduction, blood glucose control, dietary strategies, exercise for muscle retention, and lifestyle changes to prevent weight regain
In summary, Bifidobacterium may help delay the progression of liver diseases related to steatosis and insulin resistance by enhancing the intestinal barrier, inhibiting pro-inflammatory pathways, and activating the FXR receptor
The role of receptor kinases and arrestins in G protein-coupled receptor regulation
There is a lot of room to work with here
assess the effect of L-carnitine on VLDL cholesterol level and no significant correlation was found.[] However, L-carnitine may change metabolic pathways from esterification in the liver and change TG synthesis to ALC, which can reduce the synthesis of TG and VLDL cholesterol.[] Also, catabolism of VLDL is reduced in individuals with diabetes, which is due to decreased activity of LPL in adipose tissue leading to augmented levels of TG in individuals with diabetes
